# Optical Coherence Tomography (OCT) Evaluation of Re-endothelization: A Comparison of the Intrepide™ Stent Versus Taxus™

> **NCT00914420** · PHASE4 · UNKNOWN · sponsor: **Clearstream Technologies Ltd.** · enrollment: 40 (estimated)

## Conditions studied

- Coronary Artery Disease
- Acute Coronary Syndrome

## Interventions

- **DEVICE:** Intrepide Trapidil eluting stent
- **DEVICE:** Taxus drug eluting stent

## Key facts

- **NCT ID:** NCT00914420
- **Lead sponsor:** Clearstream Technologies Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-06
- **Primary completion:** 2010-11
- **Final completion:** 2012-10
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2010-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00914420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00914420, "Optical Coherence Tomography (OCT) Evaluation of Re-endothelization: A Comparison of the Intrepide™ Stent Versus Taxus™". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00914420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*